Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: azithromycin / dextromethorphan / doxycycline / keflex / xanax attending: chief complaint: presents for stent placement for tracheobronchomalacia major surgical or invasive procedure: rigid bronchoscopy, flexible bronchoscopy, y silicone stent placement (#16 with a tracheal limb of 6.5 cm, a left mainstem limb of 2.5 cm and a right mainstem limb of 1.1 cm.) history of present illness: 66 year old female with hx of tracheobronchomalacia s/p y stent in , complicated by granulation tissue in right and left mainstem bronchi s/p stent removal in . after initial stent placement reported improvement in respiratory symptoms. unfortunately developed granulation tissue at the distal end of the silicone stent requiering removal. since removal, reports increase in dyspnea and recurrent respiratory infections. she reports a weight gain of about 37lbs over 4 months. she is admitted to on for a flexible +/- rigid bronchoscopy with possible re-stenting. past medical history: tracheobronchomalacia s/p silicone y stent in , removed in copd-oxygen and steroid dependent diabetes mellitus type 2 on insulin with diabetic neuropathy seizue disorder posttraumatic stress disorder since she had a fire accident in her house hypercoagulable state with deep venous thrombosis and pulmonary emoblism for which she is on chronic coumadin hypercholesterolemia gerd essential tremor thyroid nodules biopsy showed colloid anxiety chronic (stable) diastolic dysfunction social history: married, lives with husband. : 100 pack year, discontinued in etoh none, denies any exposure history family history: mother had diabetes and lung cancer. father had emphysema. she has a brother with a heart condition, another brother with cancer, and a sister with diabetes. she had three children who died in an accidental fire in . physical exam: 99.0 84 130/64 24 100%3l nc nad rrr rales b/l soft nt/nd pertinent results: admission labs: 10:32pm blood wbc-26.5*# rbc-4.28 hgb-11.8* hct-36.2 mcv-85 mch-27.6 mchc-32.7 rdw-15.3 plt ct-466*# 04:40am blood pt-12.9 ptt-26.5 inr(pt)-1.1 10:32pm blood glucose-150* urean-22* creat-0.8 na-142 k-3.8 cl-100 hco3-27 angap-19 10:32pm blood calcium-9.5 phos-3.7 mg-1.6 at discharge: 06:40am blood wbc-14.8* rbc-3.68* hgb-10.1* hct-31.5* mcv-86 mch-27.5 mchc-32.2 rdw-15.5 plt ct-366 06:40am blood pt-14.4* inr(pt)-1.3* 06:40am blood urean-35* creat-1.0 k-3.6 07:30am blood calcium-9.5 phos-2.8 mg-2.3 imaging: cxr: there may be some atelectasis in the right lower lobe, but lung volumes are generally normal, and the portions of the lungs are not obscured by cardiac silhouette, appear clear. there is no pleural effusion. heart is borderline enlarged, exaggerated by mediastinal fat. lordotic positioning exaggerates caliber of the upper mediastinum, which the ct scan showed is infiltrative with fat. cxr: nonphysiologic straightening of the walls of the lower trachea and main bronchi are the only indication of the tracheobronchial y-stent, which is barely radiopaque. new heterogeneous opacification in the right lower lobe is consistent with substantial aspiration or developing pneumonia. the lungs are otherwise clear. heart size top normal. there is no pleural effusion or evidence of central adenopathy. et tube and nasogastric tube are in standard placements. no pneumothorax microbiology: 4:56 am sputum source: endotracheal. **final report ** gram stain (final ): >25 pmns and <10 epithelial cells/100x field. 4+ (>10 per 1000x field): gram negative diplococci. 2+ (1-5 per 1000x field): gram positive cocci. in pairs. respiratory culture (final ): rare growth oropharyngeal flora absent. moraxella catarrhalis. heavy growth. brief hospital course: mrs. was admitted to the interventional pulmonology/thoracic surgery service following a rigid bronchoscopy, flexible bronchoscopy, y silicone stent placement (#16 with a tracheal limb of 6.5 cm, left mainstem limb of 2.5 cm and a right mainstem limb of 1.1 cm.) on . post- procedure she was doing well, althought 8 hrs after developed acute respiratory distress, failed niv and required endotracheal intubation. she also had low urine output, which she received 2-250cc lr boluses and lasix. she was transferred to the surgical icu for close monitoring and care. on pod 1 () she underwent a bedside flexible bronchoscopy with clearing of a mucous plug. a chest xray showed likely pneumonia and she was started on vancomycin and levaquin. she was able to be extubated and was continued on bipap for respiratory support. on pod 2 () she was tolerating 02 by nasal cannula and she was started on a diet and transferred to the floor. the vancomycin was d/c'd and she was continued on levaquin. she was also started on prednisone 60mg to be tapered over 2 weeks. she was continued on advair, mucinex, albuterol/mucomyst nebs, spiriva and nebulized saline with chest pt. she continued to do well on the floor and was seen by physical therapy who recommended outpatient pulmonary rehab. her prednisone was slowly tapered and she was given a prescription for a continued taper at d/c. she was ambulating well, voiding normally and tolerating a regular diet. she was restarted on lovenox on and given a 5mg dose of coumadin on . her inr at discharge was 1.3. she will have an inr drawn monday and follow up with her previous coumadin clinic for dosing. she will continue lovenox until her inr>2.0. she was stable for discharge home on . she will continue on her home 02. she will continue on levaquin for a total of 8 days and was given a prescription and contact information for pulmonary rehab. she will follow up with dr. in weeks. medications on admission: albuterol, lipitor 20', benzonatate 200"', sinemet 25/100", klonopin 0.5', cardizem 240', lovenox 80" (in lieu of coumadin 5'), tricor 48', 180', flovent 220", vicodin, atrovent, isosorbide mono 30', metolazone 2.5' (off lasix 80'), mirtazapine 15', singulair 10', prilosec 20', kcl, prednisone 10', zoloft 100', theophylline 200", spiriva 1', fe 325', guaifenesin 600", nph 35am 9pm + ss discharge medications: 1. sertraline 100 mg tablet sig: one (1) tablet po daily (daily). 2. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 3. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). disp:*1 disk with device(s)* refills:*2* 4. prilosec 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. 5. mirtazapine 15 mg tablet sig: one (1) tablet po at bedtime. 6. klor-con m20 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day. 7. lipitor 20 mg tablet sig: one (1) tablet po once a day. 8. mucinex 600 mg tablet sustained release sig: two (2) tablet sustained release po twice a day. 9. enoxaparin 80 mg/0.8 ml syringe sig: one (1) subcutaneous q12h (every 12 hours): until inr 2.0 or greater then stop. disp:*12 80mg/0.8ml* refills:*2* 10. coumadin 5 mg tablet sig: one (1) tablet po once a day: take as directed to maintain inr 2.0-3.0. 11. levofloxacin 500 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 6 days. disp:*6 tablet(s)* refills:*0* 12. carbidopa-levodopa 25-100 mg tablet sig: one (1) tablet po twice a day. 13. clonazepam 0.5 mg tablet sig: one (1) tablet po once a day. 14. tricor 48 mg tablet sig: one (1) tablet po once a day. 15. fexofenadine 180 mg tablet sig: one (1) tablet po once a day. 16. imdur 30 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. 17. lisinopril 2.5 mg tablet sig: one (1) tablet po once a day. 18. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 19. prednisone 5 mg tablet sig: take as directed tablet po once a day: taper start sunday : take 50mg x 1 days, 45mg x 3 days, 40mg x 3 days & 35mg x 3days, 30mg x 3 days, 25 mg x 3days, 20 mg x 3 days, 15 mg x 3days, then continue 10 mg maintenance dose daily. disp:*120 tablet(s)* refills:*0* 20. xopenex 1.25 mg/0.5 ml solution for nebulization sig: one (1) inhalation three times a day. 21. theophylline 200 mg capsule, sust. release 12 hr sig: one (1) capsule, sust. release 12 hr po twice a day. 22. tessalon perle 100 mg capsule sig: two (2) capsule po three times a day. 23. serevent diskus 50 mcg/dose disk with device sig: one (1) inhalation twice a day. 24. novolin n 100 unit/ml suspension sig: as directed subcutaneous twice a day. 25. keppra 500 mg tablet sig: one (1) tablet po three times a day. 26. hydrocodone-acetaminophen 5-500 mg capsule sig: capsules po three times a day as needed for pain. 27. ferrous sulfate 325 mg (65 mg iron) capsule, sustained release sig: one (1) capsule, sustained release po once a day. 28. mucomyst 20% solution {800/4ml} and mix with xopenex 1.25/0.5 mg/ml nebs q6hrs 29. trazodone 100 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. 30. diltiazem hcl 240 mg capsule, sustained release sig: one (1) capsule, sustained release po once a day. 31. nebulizer continue saline nebulizer treatment every 6 hours 32. lidoderm 5 %(700 mg/patch) adhesive patch, medicated sig: one (1) patch topical once a day as needed for pain: apply for 12 hours on, 12 hours off. disp:*14 patches* refills:*0* 33. outpatient physical therapy outpatient pulmonary rehab: eval and treat dx: tracheobronchomalacia, copd with home o2 use discharge disposition: home discharge diagnosis: tbm s/p y-stent placement complicated by mucus plug and post operative respiratory distress requiring intubation for 8hrs copd (steroid dependent, home o2), dm2, seizure disorder, ptsd, pe on coumadin, hypercholesterolemia, gerd, essential tremor, thyroid nodule, anxiety, depression, and diastolic chf, hypertension discharge condition: stable discharge instructions: call dr. office if experience: fever > 101 or chills, cough, increased shortness of breath, sputum production, chest pain. prednisone taper: 50mg for 1 days, 45mg x 3 day, 40mg, 3 days & 35mg x 3days, 30mg x 3 days, 25 mg x 3days, 20 mg x 3 days, 15 mg x 3days, then continue 10 mg maintenance dose daily lovenox 80 mg twice daily: until inr 2.0 or greater then stop take coumadin 5mg on saturday, coumadin 2.5 mg sunday: blood draw on monday for inr check and follow-up with clinic as previous to manage your coumadin dose. continue the levaquin antibiotic for 6 more days. you have a prescription order for outpatient pulmonary rehab. please call one of the facilities on the list you were given to schedule an appointment. followup instructions: call dr. office on monday for a 2 week follow-up appointment you have a prescription order for outpatient pulmonary rehab. please call one of the facilities on the list you were given to schedule an appointment. md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube fiber-optic bronchoscopy fiber-optic bronchoscopy other intubation of respiratory tract closed [endoscopic] biopsy of bronchus diagnoses: pneumonia, organism unspecified esophageal reflux pure hypercholesterolemia congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes personal history of tobacco use dysthymic disorder long-term (current) use of insulin long-term (current) use of anticoagulants personal history of venous thrombosis and embolism chronic diastolic heart failure other diseases of trachea and bronchus acute edema of lung, unspecified family history of diabetes mellitus family history of malignant neoplasm of trachea, bronchus, and lung posttraumatic stress disorder essential and other specified forms of tremor family history of colonic polyps 

Answer: The patient is high likely exposed to